Your session is about to expire
← Back to Search
BI 1291583 for Bronchiectasis
Study Summary
This trial evaluates if a medicine (BI 1291583) helps adults with bronchiectasis. Participants take the medicine daily for up to a year & visit study site 9 times. Doctors check if medicine helps reduce symptoms.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a positive test for hepatitis B, hepatitis C, or HIV. If these test results change after you join the study, you may not be able to continue participating.I have been newly diagnosed with extensive warts.I have been newly diagnosed with a lung condition due to a fungal infection and need treatment.I have been newly diagnosed with a skin condition on my palms or soles.I have been newly diagnosed with low immune proteins.I haven't had a serious lung infection in the last 4 weeks.I have been newly diagnosed with common variable immunodeficiency.I am newly diagnosed with α1-antitrypsin deficiency and am receiving augmentation therapy.My kidney function is very low, with an eGFR below 30 mL/min.I have signed and understand the consent form for this trial.I have moderate to severe liver disease or my liver tests are more than three times the normal limit.I have not had a live vaccine in the last 4 weeks.I am being treated for a new tuberculosis or similar infection.I am either male or female.I have been newly diagnosed with reactive arthritis or keratoderma blennorrhagicum.Your blood neutrophil count is less than 1,000 cells per microliter.I have a new diagnosis of hypothyroidism or related conditions, or my hypothyroidism is under control with treatment.I have a fungal infection on my hand or feet that hasn't improved with treatment.I have been newly diagnosed with pityriasis rubra pilaris.You finished the treatment as planned in a previous study.I have a new diagnosis of eczema on my hands and feet or it covers 10% or more of my body.I have been newly diagnosed with psoriasis on my palms and soles, or it covers 10% or more of my body.I haven't taken any antibiotics or antifungal medications in the last 4 weeks.You have a medical condition that could make participating in the trial risky, such as certain immune system disorders or other serious health issues.
- Group 1: BI 1291583 high dose arm
- Group 2: BI 1291583 low dose arm
- Group 3: BI 1291583 medium dose arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper limit of enrollees participating in this research?
"Affirmative. Clinicaltrials.gov shows that this clinical trial is actively recruiting, having been posted on July 21st of 2023 and last updated on the 26th of the same month. A total of 220 patients are needed at 1 site to complete this study."
What security measures are in place to protect participants involved with the Low dose arm of Part A?
"Our analysts at Power rated the safety of Part A: Low dose arm a 2 as it is only currently in Phase 2, meaning that while there is data verifying its security, none exists to validate its efficacy."
Are there still any open slots for participation in this experiment?
"Affirmative. According to the clinicaltrials.gov page, this medical investigation is still looking for participants and was first published on July 21st 2023. The latest update occured five days later. Currently, 220 subjects are needed from one site of research."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger